![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 45, 42549-42556, November 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Chemistry and Biochemistry, Texas Tech
University, Lubbock, Texas 79409-1061
Received for publication, April 30, 2002, and in revised form, August 22, 2002
Sterol methyltransferase
(SMT) from Saccharomyces cerevisiae was purified from
Escherichia coli BL21(DE3) and labeled with the
mechanism-based irreversible inhibitor
[3-3H]26,27-dehydrozymosterol (26,27-DHZ). A 5-kDa
tryptic digest peptide fragment containing six acidic residues at
positions Glu-64, Asp-65, Glu-68, Asp-79, Glu-82, and Glu-98 was
determined to contain the substrate analog covalently attached to
Glu-68 by Edman sequencing and radioanalysis using C18
reverse phase high performance liquid chromatography.
Site-directed mutagenesis of the six acidic residues to leucine
followed by activity assay of the purified mutants confirmed Glu-68 as
the only residue to participate in affinity labeling. Equilibration
studies indicated that zymosterol and 26,27-DHZ were bound to native
and the E68L mutant with similar affinity, whereas
S-adenosylmethionine was bound only to the native SMT,
Kd of about 2 µM. Analysis of the
incubation products of the wild-type and six leucine mutants by GC-MS
demonstrated that zymosterol was converted to fecosterol, 26,27-DHZ was
converted to 26-homo-cholesta-8(9),23(24)E,26(26')-trienol
as well as 26-homocholesta-8(9),26(26')-3 The sterol methyltransferases
(SMTs)1 are appealing targets
in the design of enzyme inhibitors, because they lie on a pathway with
no counterpart in human physiology (1, 2). These enzymes are unique for
catalyzing the biosynthesis of 24-alkyl sterol membrane inserts in
microorganisms (3, 4). Several substrate analogs have been designed to
mimic the topological and electrostatic features of the transition
state for the C-methylation reaction and several of these compounds,
including 24(R,S),25-epiminolanosterol and
25-aminolanosterol (5), markedly inhibit growth of microbes associated
with human disease (6-9).
The SMT from the yeast Saccharomyces cerevisiae has been
cloned and overexpressed in Escherichia coli BL21(DE3)
cells, and purified to homogeneity (10, 11). The enzyme is a tetramer of molecular weight 172,000 and its activity is subject to
down-regulation by ergosterol and up-regulation by ATP (1). Comparison
of protein sequences deduced from the cDNA for fungal SMTs (Fig.
1) revealed a highly conserved region
rich in aromatic amino acids, referred to as Region I, containing a
signature motif Y81EYGWG86 not present in other
AdoMet-dependent methyltransferases. As each of these enzymes uses zymosterol 1A as the sterol acceptor molecule, the aromatic-rich domain of Region I has been proposed to be involved in substrate binding, and possibly product formation, by stabilizing intermediate carbenium ions generated during sterol C-methylation (11).
A general stereochemical model (the "steric-electric plug" model)
for the coupled Si face ( A central feature of the steric-electric plug model is the predicted
intermediacy of a high energy intermediate 2 that can be
converted to a
Active Site Mapping and Substrate Channeling in the Sterol
Methyltransferase Pathway*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
,24
-dienol, and in the
case of D79L and E82L mutants, zymosterol was also converted to a new
product, 24-methylzymosta-8,25(27)-dienol. The structures of the
methylenecyclopropane ring-opened olefins were determined unambiguously
by a combination of 1H and 13C NMR techniques.
A Km of 15 µM,
Kcat of 8 × 10
4
s
1, and partition ratio of 0.03 was established for
26,27-DHZ, suggesting that the methylenecyclopropane can serve as a
lead structure for a new class of antifungal agents. Taken together,
partitioning that leads to loss of enzyme function is the result of
26,27-DHZ catalysis forming a highly reactive cationic intermediate
that interacts with the enzyme in a region normally not occupied by the
zymosterol high energy intermediate as a consequence of less than
perfect control. Alternatively, the gain in enzyme function resulting
from the production of a
25(27)-olefin originates with
the leucine substitution directing substrate channeling along different
reaction channels in a similar region at the active site.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
- or back face attack)
C-methylation of the zymosterol
24-bond 1A
and subsequent deprotonation of C-28 with concerted migration of
hydrogen to fecosterol 3A has been proposed based primarily
on differential inhibition and isotopic labeling studies, as well as
recent investigations involving product outcomes resulting from
site-directed mutagenesis experiments on SMT action (12-14).
![]()
View larger version (21K):
[in a new window]
Fig. 1.
Comparison of the 26,27-dehydrozymosterol
binding site sequence of S. cerevisiae SMT with
related sequences from other fungi. Note the alignment of the
aromatic-rich signature motif YEYGWG (boxed), the
nonconserved Glu-68 affinity labeled with 26,27-DHZ, and the six acidic
amino acids (bold) mutated to leucine.
24(28)-
25(27)- or
23(24)-olefinic product (Scheme
1). The usual paradigm for the formation of sterol side chain olefins such as fecosterol from zymosterol in
fungi or cyclolaudenol 4B and cyclosadol 5B from cycloartenol 1B in algae and vascular plants, respectively, requires distinct SMTs to generate the variant isomers. However, recent
studies with SMTs from fungi and plants employing a range of sterol
acceptor molecules and isotopically branching sensitive experiments
evoke a common set of enzymatic intermediates involved with the
stereochemically related events, electrophilic alkylations, rearrangements, and deprotonations (14, 15). Because no gene encoding a
protein
23(24)- or
25(27)-SMT activity
has been previously identified we were unable to identify consensus
motifs that might contribute to the unique regioselectivity of the
catalysts. Instead, we performed site-directed mutagenesis of a highly
conserved aromatic amino acid residue in Region I, Tyr-81, to establish
whether Region I contributes to regiocontrol in the reaction.
Unexpectedly, the Y81F mutant exhibited altered substrate specificity
catalyzing the successive C-methylation of desmosterol 1C to
24(28)-methylene cholesterol 3C and to a mixture of multiple
doubly alkylated sterols found in primitive vascular plants (16),
including isofucosterol 7C, fucosterol 8C, and
clerosterol 9C. The Y81F mutant SMT failed to
generate a mono-alkyl structure other than the
24(28)-methylene product from a
24(25)-substrate.

View larger version (16K):
[in a new window]
Scheme 1.
A major determinant that controls product diversity is believed to be
the precise conformation of the sterol side chain at the sterol binding
site (14, 17). Although many of the mechanistic and stereochemical
details of the C-24 alkylation pathways have been verified (18, 19),
little is known about the active site of any SMT or the manner in which
a SMT enzyme imposes a particular conformation on its acceptor
molecule, precisely controls the coupled-methylation deprotonation
reaction, and establishes kinetic and substrate specificity for
C1- and the successive C1-methyltransfers ultimately giving rise to the side chains of fungal ergosterol and
plant sitosterol, respectively. We recently reported the first potent
mechanism-based inactivator of S. cerevisiae SMT,
26,27-dehydrozymosterol (26,27-DHZ), which made it possible to
stoichiometrically and covalently modify the active site of the enzyme
(20). A tryptic digest fragment containing the inhibitor-peptide adduct
was sequenced and found to be contiguous with Region I. The mechanism
of inhibition and covalent attachment of 26,27-DHZ responsible for
trapping an active site nucleophile suggested nucleophilic attack of
the
24-bond of the S-methyl group of AdoMet
leading to a reactive ring-opened intermediate,
25(27)-olefin 14, shown in Scheme
2, in an analogous manner to the
mechanism proposed for the catalysis of
6-cyclopropylidene- 3E-methyl-hex-2-en-1-yl-diphosphate
for monoterpene cyclase (21).
|
In this paper, we demonstrate that 26,27-DHZ reacts specifically with
Glu-68. The structure of the activated 26,27-DHZ intermediate that
leads to enzyme inactivation and the structure of the C-methylation turnover product reveal a novel mode of C-methylation catalysis that is
different from the mechanism of irreversible inactivation of
monoterpene cyclase by
6-cyclopropylidene-3E-methyl-hex-2-en-1-yl-diphosphate. In addition, we describe product analyses and kinetic results for
site-directed mutagenesis studies that implicate key acidic amino acids
in Region I, themselves not required for catalytic activity, capable of
directing substrate channeling to produce multiple olefins.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials-- The sources of reagents and substrates zymosterol, fecosterol, 26,27-dehydrozymosterol, [3-3H]26,27-dehydrozymosterol ([3-3H]26,27DHZ, 9.0 µCi/µmol), [methyl-3H3]AdoMet (10.8 µCi/µM), [methyl-2H3]AdoMet (99.3 2H3% enrichment), and MSD isotopes, and chromatographic materials were as described in our preceding papers (12, 21). An antibody to the pure S. cerevisiae SMT was a gift of Dr. M. Venkatramesh at Monsanto Co. and was purified according to the manufacturer's protocol using a serum IgG purification kit supplied by Bio-Rad.
General Methods--
General methods for spectroscopic analysis,
heterologous expression, and homogenate preparation and analysis,
steady-state kinetic experiments, and protein purification were as
described (12, 13). The initial velocity data were determined using a
Sigma plot 2001 plus Sigma enzyme kinetic program (SSPS Inc). Measurement of Km(app) and
Vmax(app) for sterol employed a concentration
range of 5 to 200 µM. Data were fitted to the equation,
v = Vmax*
(S/Km + S), using a nonlinear least square
approach. Kinetic constants possessed ± S.E. of ±5% and R2 values = 0.95 to 0.97. GC-MS analyses
were performed on a Hewlett-Packard 6890 gas chromatograph-mass
spectrometer. Routine protein concentrations were estimated according
to the method of Bradford with commercial reagents (Bio-Rad) using
bovine
-globulin as standard (23).
Plasmid Construction of Mutant SMTs-- Point mutations were generated using the QuikChangeTM site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions, which includes the use of the proofreading thermostable DNA polymerase from Pyrococcus furiosus. Mutagenic oligonucleotides had 23-28-bp overlap with the cDNA sequence before and after the mutated codon, and a melting temperature equal or greater than 78 °C (as per Stratagene's instruction manual). Oligonucleotide sequences of mutagenic primers are listed in Table I. The recombinant pET23a-ERG6 was used as the mutagenesis template. Mutations were introduced into bp 161-163, 163-165, 271-273, 306-308, 315-317, and 363-365 of ERG6 wild type cDNA, to generate six mutant ERG6 proteins. The mutant ERG6 proteins had the following single amino acid changes: E64L, D65L, E68L, D79L, E82L, and D98L. Following DpnI treatment of the mutagenic PCR product, the mutant plasmids were transformed into BL21(DE3) competent cells (from Novagen). All the mutations were verified by automated DNA sequencing to ensure that only the desired mutations and no other changes were inserted into the cDNA.
|
Expression and Assay of Native and Mutant SMTs-- Native and engineered proteins were expressed in BL21(DE3) cells as previously described (14) with minor modifications as follows. Briefly, transformed cells in BL21(DE3) cultures were grown in LB medium containing 50 mg/ml ampicillin overnight. Harvested cells were lysed using a French press, followed by generation of a 100,000 × g supernatant used for analysis of product distribution. The 100,000 × g fraction was purified to apparent homogeneity for Kcat determinations as described (14). The initial velocity versus substrate concentration curves for the SMT-catalyzed C1-transfer reaction were determined using a fixed [methyl-3H3]AdoMet concentration of 50 µM and varying the concentration of sterol at 5, 10, 15, 25, 75, 100, 150, and 200 µM (final concentration). The two substrates dissolved in Tween 80 (1.0%, v/v) were incubated with 0.68 µM total protein at 35 oC C4 for 45 min. The conversion of zymosterol to products was assayed by counting total radioactivity in the nonsaponifiable lipid fraction of the quenched enzyme assay and plotted according to the method of Lineweaver-Burk. Further assessment of the enzyme-generated products was by GC-MS analysis of the nonsaponifiable lipid fraction of activity assays performed overnight at saturating levels of zymosterol and AdoMet.
Detection of SMT Proteins--
Aliquots of total and soluble
(100,000 × g supernatant) protein from crude E. coli homogenates harboring native or mutant cDNA of the SMT,
prepared as described (14), were separated on an 12%
SDS-polyacrylamide gel and stained for total protein using Coomassie
Blue. The stained gels were scanned with a Amersham Biosciences
densitometer, and the density of the
isopropyl-1-thio-
-D-galactopyranoside inducible band
(corresponding to the predicted molecular weight for the SMT protein of
about 43,000) was determined as a percentage of the total density of
the scan. In addition, Western blot analysis for the expressed proteins
using the native SMT antibody was performed under the same
chromatographic conditions to estimate SMT levels (14).
The Inhibitor-peptide Adduct-- Chemical affinity labeling using pure SMT (0.83 µg), AdoMet (100 µM), and [3-3H]26,27-DHZ (100 µM) was as described (19). The affinity labeled protein was digested with trypsin and the resulting inhibitor-peptide adduct was separated using a 20% SDS-PAGE gel system. The amino acid sequencing of the isolated radioactive 5-kDa fragment (2.5 × 105 disintegrations/min) was carried out on an aliquot (2.5 × 104 disintegrations/min) of the excised material using a Porton (Beckman) automated sequencer with on-line Beckman Gold HPLC. Standard Beckman gradient protocols for the micro-phenylthiohydantoin column system were followed for phenylthiohydantoin-derivative separation and identification. Radioactivity of sequencing eluates was determined by liquid scintillation counting (Beckman, LS-6500).
Binding Assay--
Determination of the dissociation constant
(Kd) for zymosterol and AdoMet was performed by the
filtration method, adapted from Ref. 24. Briefly, Kd
for the two ligands was established using pure native and mutant SMT
expressed in BL21(DE3) cells. Assay conditions for AdoMet involved
dissolving the ligand in a 1.7-ml reaction vessel containing 100 µl
of buffer A (50 mM Tris-HCl (pH 7.5), 2 mM
MgCl2, 1 mM EDTA, 2 mM
-mercaptoethanol, and 5% glycerol) at pH 7.5, 0.57 µM
SMT and incubated at 32 °C. For sterol, Tween 80 (1% w/v) was added
to the vial to assist solubilizing the sterol. The
Kd for AdoMet and sterol was determined by
aliquoting 0.04 to 3.76 µM and 0.25 to 10 µM, respectively, to the reaction vessel. After 2.5 h of equilibration on a level shaker, the protein-ligand complex was
put on a GF/B glass filter disk (disks were 2.5 cm diameter, Whatman).
The filter disks were pretreated with 1 mg/ml bovine serum albumin
solution at 4 °C overnight to prevent nonspecific binding of the
ligand to the disk. Ligand-bound proteins were washed 3 times, 500 µM each, with ice-cold buffer A. The disk was air dried
and counted by liquid scintillation to determine the amount of
radioactivity that remained on the disk from which the amount of bound
ligand was determined. Nonspecfic binding was determined in the
presence of 100-fold of excess unlabeled AdoMet or sterol. At the
specified concentration of ligand, all potential sites of the enzyme
are assumed to be saturated and any radioactivity recovered from the assay was viewed to be from nonspecific binding. In no case was nonspecific binding greater than 10%. Binding of AdoMet was
independently performed in two 5-cell Scienceware, H420260-0000,
equilibrium dialyzers at 32 °C. Equilibration conditions employed 1 ml of buffer A, in each chamber, and 0.57 µM purified
enzyme. The Kd value for AdoMet in the presence of
SMT was determined by transferring 0.07 to 3 µM
[methyl-3H3]AdoMet to the buffer
chamber and SMT to the protein chamber. Each side of the cell was
separated by Spectrapor membranes with cut-off
Mr = 6,000 to 8,000. After a 8-h incubation on a
level shaker, aliquots were recovered from each chamber, and the
radioactivity was measured in a Beckman LS6000 liquid scintillation
analyzer to determine the amount of radioactivity in the buffer chamber ([AdoMet]free) and the protein chamber
([AdoMet]free + [AdoMet·SMT]). The calculated
[AdoMet]free was subsequently substracted from the
calculated concentration of bound SMT. The data were presented in
hyperbolic form (Equation 1). The bound ligand (AdoMet or sterol) concentration B was plotted as a function of free ligand
concentration, [L]f. The Kd value was
estimated using a computer program (Sigma plot 2001 plus Ligand binding
Marco SSPS, Inc.) by nonlinear least-squares analysis of B
versus [L]f plot fitting to the standard Langmuir-type binding equation,
|
(Eq. 1) |
| |
RESULTS |
|---|
|
|
|---|
Identification of the Amino Acid Residue Labeled with
[3-3H]26,27-DHZ--
To localize the site affinity
labeled with the mechanism-based inactivator in the primary structure,
a trypsin digest fragment of about 5 kDa was prepared from SMT that had
been treated with [3-3H]26,27-DHZ. The labeled 5-kDa
peptide was subjected to Edman degradation to give an unambiguous
sequence of 19 amino acids. The radioactivity associated with the
covalently attached irreversible inhibitor was detected between the
fifth to tenth cycles (about 80% of the tritium injected into the
column was recovered in these fractions) with the major peak of
radioactivity eluting in the seventh sequencing cycle (Fig.
2). On the basis of these results, we
concluded that Glu-68 was specifically labeled with the inhibitor and
represents the putative acidic amino acid residue attached to
[3-3H]26,27-DHZ. However, because the 5-kDa trypsin
digest fragment is expected to contain 45 amino acids and six acidic
residues at positions Glu-64, Asp-65, Glu-68, Asp-79, Glu-82, and
Asp-98 (Fig. 2), it was unclear whether the two additional acidic amino acid residues at positions Glu-82 and Glu-98 not involved in the Edman
sequencing of the peptide might also be affinity labeled with the
irreversible inhibitor. Therefore, additional experiments were carried
out to confirm Glu-68 as the only residue attached to
[3-3H]26,27-DHZ in the SMT.
|
Effects of Mutations of Acidic Residues on Catalysis and Binding
Affinity--
In the initial series of experiments it was of interest
to establish whether any of the acidic amino acids in the tryptic digest were catalytically dysfunctional. A set of SMT mutants were
constructed by site-directed mutagenesis in which the relevant acidic
amino residue in the tryptic digest fragment was replaced with leucine.
Each of the resulting mutants was expressed in BL21(DE3) cells to
similar levels as the wild-type cDNA as revealed by Western blot.
The mutant enzymes were subsequently purified in a similar manner to
homogeneity, suggesting that none of the mutant proteins were
significantly altered conformationally. The steady-state kinetic
parameters determined using zymosterol as the sterol acceptor molecule
for the mutants are reported in Table II.
Although there are differences in the catalytic competence among E86L,
D65L, E79L, E82L, and E98L mutants, they were active while E68L was inactive, thereby indicating only Glu-68 is a critical amino acid in
the catalysis of 26,27-DHZ. When the amount of enzyme was increased by
10-fold, the E68L mutant continued to fail to exhibit appreciable activity. The rate of catalysis observed for the E98L mutant approached the lower limit of detection in our activity assay system. Nonetheless, we could measure the kinetic constants for 26,27-DHZ using the wild-type SMT, which were Km of 15 µM
and Kcat of 8 × 10
4
s
1. From our earlier incubations with the recombinant
yeast SMT, the ki and Kinact
of 1.1 µM and 1.52 min
1, respectively, were
determined (20). The partition ratio, a measure of the production of
product per inactivation event, can now be calculated from the ratio
kcat26,27-DHZ/kinact26,27DHZ, to be 0.03, suggesting 26,27-DHZ to be a potent inhibitor of SMT action.
|
Binding experiments were performed to definitively confirm that the
E68L mutant can bind sterol thereby confirming that the structure of
the mutant was not changed significantly by the amino acid replacement.
As shown in Fig. 3, zymosterol binds to
the native SMT with a Kd of about 2 µM
and 26,27-DHZ binds with a similar Kd value (data
not shown). Scatchard analysis of the binding data revealed a single
binding site for sterol (Fig. 3). AdoMet also binds to the native SMT
with similar affinity as the sterols to SMT, Kd of
0.5 ± 0.08 µM (Fig. 3). Equilibrium dialysis gave a
similar binding isotherm for AdoMet generating a Kd
of 4 µM. Based on the two methods, the Kd of AdoMet is about 2 µM. By
comparison, the Kd for zymosterol and 26,27-DHZ to
the E68L mutant was about 5 µM, whereas AdoMet failed to
bind at all (no saturation of the enzyme was evident). The leucine
substitution appears to generate an impaired active center that
prevents productive binding of AdoMet and this may be the reason for
inactivity. Because the Y81F mutant can C-methylate fecosterol
producing a mixture of 24-ethyl (and ethylidene) sterols (14),
fecosterol was tested as a substrate with each of the Leu mutants. In
no case was fecosterol a suitable substrate for SMT action.
|
Identification of Products of Zymosterol Catalysis--
The
product profiles of the six mutants assayed with zymosterol are
summarized in Table II. Each of the active mutants produced fecosterol
3A and in the case of D79L and E82L was accompanied by a
second olefin which in GLC eluted earlier than fecosterol (retention
time relative to cholesterol of 1.16; molecular weight m/z = 398, 3A) as shown in Fig.
4. The mass spectrum of the new sterol is
identical to an authentic specimen of 24-methylzymosta-8,25(27)-dienol (retention time relative to cholesterol of 1.14; molecular weight m/z = 398, 4A) generated in a
cell-free preparation from the algal Prototheca wickerhamii
(25). Further evidence for the biosynthesis of the new sterol was by
incubation of the D79L mutant with saturating amounts of
[methyl-2H3]AdoMet and zymosterol
and analysis of the activity assay products by GC-MS. Both fecosterol
and 24-methylzymosta-8,25(27)-dienol were labeled with deuterium from
[methyl-2H3]AdoMet.
2H-Labeled fecosterol possessed a 2 mass unit increase
compared with the native fecosterol with a molecular weight of
m/z = 400 (M+ 100% and other
diagnostic ions at M+-CH3, 385 and
M+
CH3
H2O, 367). By contrast,
2H-labeled 24-methylzymosta-8,25(27)-dienol possessed a 3 mass unit increase compared with the native
24-methylzymosta-8,25(27)-dienol with a molecular weight of
m/z = 401 (M+ 100% and other
diagnostic ions at M+
CH3, 386, and
M+
CH3
H2O, 368). The results
of the deuterium incorporation studies into the sterol side chain are
consistent with the formation of a 24(28)-methylene structure (2 2H-atoms at C-28) and a CH3 structure (3 2H-atoms at C-28) thereby generating olefins 3A
and 4A, respectively.
|
Identification of Products of 26,27-DHZ Catalysis--
In our
earlier study of 26,27-DHZ assayed with yeast SMT (12, 20), we failed
to detect any product formation by GC-MS or HPLC. At the time, we were
operating on the assumption that 26,27-DHZ would elute earlier in
chromatography than its putative turnover product-12 in a
manner analogous to the GLC behavior of zymosterol to fecosterol (Fig.
4). However, upon further study, we detected two unknown compounds in a
3 to 1 ratio that are generated in 2% yield from the saponification
mixture of SMT assayed with 26,27-DHZ. From a preparative scale
incubation with AdoMet and 26,27-DHZ, two unknown compounds
were detected in the HPLC chromatogram (Phenomenex) eluting before
(
c 0.35, RRTc 1.72, M+ 414) and
coincidental (
c 0.68, RRTc 1.29, M+ 396) with the substrate 26,27-DHZ (
c
0.68, RRTc 1.29; M+ 382). The compounds eluting
at
c 0.35 (diol) and 0.68 (monol) were subsequently
purified to homogeneity using a second HPLC column (Tohohaas). NMR
analyses of the enzyme-generated products indicated retention of the
zymosterol nucleus for both the monol and diol structures (data not
shown). The relevant chemical shifts of the side chain proton atoms in
the 500 MHz spectrum of the monol showed the presence of two
exomethylene protons (
4.70 (s, 1H), 4.71 (s, 1H)) and two
additional olefinic protons transoid to one another
resonating at
5.41 (1H, m) and 5.40 (dd, 12.8, 5.7 Hz) and an
allylic methyl resonating at
1.71 (3H, s). The coupling
constants for reference to transoid and cisoid olefinic protons are reported Ref. 26. The coupling network determined from the COSY and TOCSY and the 13C NMR indicated two
double bonds in the side chain between C-23 and C-24 and C-26 and C-27.
Side chain carbon atoms for the monol: 1H NMR (500 MHz,
CDCl3)
(ppm) 1.48 (m, C-20), 0.93 (3H, d,
6.4 Hz, C-21), 1.76 (m, C-22), and 2.14 (m, C-22), 5.41 (m, C-23), 5.40 (dd, 12.8, 5.7 Hz, C-24), 2.69 (2H, d, 5.7 Hz, C-25), 4.70 (s, C-27),
and 4.71 (s, C-27), 1.71 (3H, s, C-28); 13C NMR
(125 MHz, CDCl3)
ppm 36.6 (C-20), 18.7 (C-21), 39.1 (C-22), 129 (C-23), 130.4 (C-24), 41.3 (C-25), 145.4 (C-26), 110.2 (C-27), 22.4 (C28). The UV spectrum of the monol (in EtOH) showed end absorption, confirming that the double bonds in the side chain were not
in conjugation. Incubation of 26,27-DHZ paired with
[methyl-2H3]AdoMet in the presence
of SMT generated a deuterated monol with a molecular weight of
M+ 399, suggesting that methyl to methylene transformation
failed to occur during the C-methyltransfer reaction. The
trideuterated methyl group was assigned to the terminal allylic methyl
group at C-26 by the disappearance of the signal resonating at
1.71 in the 1H NMR spectrum, which is assigned to C-28 in the
product. Thus C-28 is derived from the methyl group attached to AdoMet.
The monol is assigned structure 18.
The 1H NMR spectrum of the side chain of the unlabeled diol
showed the presence of two exomethylene protons (
4.81 (1H, s), 4.90 (1H, s), a proton geminal to the alcohol group (
3.66 (1H, m) and an
allylic methyl group (
1.77 (3H, s). Side chain carbon
atoms for diol: 1H NMR
(ppm) 1.44 (m, C-20), 0.96 (3H, d, 6.6 Hz, C21), 1.05 (m, C-22), and 1.57 (m, C-22),
1.38 (m, C-23), and 1.52 (m, C-23), 3.66 (m, C-24), 2.24 (dd, 2.9 and
13.6 Hz, C-25), and 2.07 (dd, 9.4 13. 6 Hz, C-25), 4.90 (s, C-27), and
4.81 (s, C-27), 1.77 (3H, s, C-28); 13C NMR
(ppm) 36.3 (C-20), 18.8 (C-21), 31.8 (C-22), 33.6 (C-23), 69.2 (C-24),
46.1 (C-25), 142.9 (C-26), 113.5 (C-27), and 22.4 (C-28). The COSY and
TOCSY correlation indicated connectivity between the proton at
3.66 ppm and a pair of protons at C-23 (
1.38, 1.52) and C-25 (
2.07 and 2.24), suggesting that the hydroxyl group in the side chain was
located at C-24. In addition, the protons associated with C-25 shows
connectivity with the exomethylene at C-27 and the allylic methyl group
at C-26, suggesting that the "extra methyl group" was attached to
C-26 rather to C-24. The mass spectrum of the deuterated diol following
incubation with [methyl-2H3]AdoMet
contained diagnostic fragments: M+ 417;
M+-CH3, 402; M+
H2O,
399; M+
33, 384), consistent with the diol assigned to
structure 20 (Scheme 3).
|
There was insufficient material to establish the stereochemistry of the
hydroxyl group at C-24 unambiguously. Therefore, the diol was prepared
synthetically from the C-24 aldehyde of zymosterol C-3 acetate as
outlined in Scheme 4. Aldehyde
21 was prepared as described in Ref. 27 and the general
coupling method to generate 22 was as described in Ref. 28.
The resulting diastereoisomeric mixture of 20 and
23 was resolved by HPLC (Tosohaas TSK gel, ODS-120A, 90%
MeOH/H2O). The two compounds were distinguished from each
other by their relevant physical, chromatographic, and spectral
characterizations: 24
-hydroxy 23 (HPLC, 36.0 min; m.p.,
136-137o; [
]D, + 83.7; 1H NMR
C-21,
0.94, d, J = 5.5 Hz) and 24
-hydroxy
20 (HPLC, 38.5 min; m.p., 127-128o;
[
]D, + 32.0; 1H NMR C-21,
0.96, d,
J = 6.6 Hz).
|
The Mosher (1H) method was employed to resolve whether the
enzyme-generated diol contained the 24
- or 24
-hydroxy group (29). The complete proton assignment for both the
2-methoxy-2-phenyl-2-(trifluoromethyl)acetic acid (MTPA)
(S)- and (R)-esters of synthetically prepared
20 were determined by extensive two-dimensional NMR analyses
(data not shown). The
(
S
R) values shown in Scheme
5 for the (S)- and
(R)-MTPA indicate that the configuration of the 3-hydroxy
and 24-hydroxy groups are
-oriented. Because the enzyme-generated
diol co-elutes with the synthetic diol used to prepare the MTPA esters,
the configuration of the 24-hydroxyl group in the natural product must
be
-oriented. The D79L and E82L mutants were assayed with saturating
amounts of 26,27-DHZ and AdoMet overnight. The resulting product yield
and ratio of monol and diol were equivalent to a similar activity assay
performed with wild-type enzyme.
|
| |
DISCUSSION |
|---|
|
|
|---|
According to the steric-electric plug model, C-methylation of
zymosterol by yeast SMT is to occur via a noncovalent pathway whereby
methyl addition to
24 and deprotonation of C-28 gives
rise to a nucleophilic rearrangement in which H-24 migrates to C-25 on
the Re face of the substrate double bond in concert with the
initial ionization. Kinetic studies indicate a random Bi Bi mechanism
for sterol C-methylation (22). Until recently, few details of protein
structure were available that would lend credence to the hypothesized
mechanism. It was proposed that a set of aromatic amino acids in the
active site would direct folding of the sterol side chain into an
appropriate catalytic conformation for C-methylation and stabilize the
positively charged high energy intermediate during rearrangement (12,
17). In addition, it was proposed that a carboxylate anion would serve as the deprotonating agent of C-28 methyl and concurrently act as an
enzymatic counterion to AdoMet (30).
To date, however, no SMT has been crystallized, therefore no three-dimensional structure is available to assist in the analyses. We therefore conducted further affinity labeling using 26,27-DHZ and site-directed mutagenesis experiments with the yeast SMT to determine the precise location of a general base in the active site and to gain information on the role of acidic amino acids in the tryptic digest fragment. Our observation that 26,27-DHZ binds irreversibly to the Glu-68 of yeast SMT suggests the residue is situated in a subsite of the active center. The formation of fecosterol by leucine mutants Glu-64, Asp-65, Asp-79, Glu-82, and Glu-98 but not by the E68L mutant, offers additional support for the involvement of Glu-68 in catalysis of sterol acceptor molecules, including 26,27-DHZ.
The C-methylation of 26,27-DHZ was directional, that is, it was
initiated through a backside nucleophilic attack of a methyl group on
the methylenecyclopropane leading to ring opening and ring expansion.
The termination step gives rise to either olefinic (elimination) or
hydroxyl (water addition) products. Ring strain and the rich
-electron density associated with the overlapping sp2 systems of the monosubstituted cyclopropane
ring of 26,27-DHZ make the cyclopropanoid susceptible to C-methylation
from AdoMet and nucleophilic rupture leading to selectivity with
respect to the direction of bond cleavage (Scheme 3). We propose that
the C-methylation-elimination reaction involving 26,27-DHZ proceeds by
the C-methylation of C-26 of substrate 10 followed by formation of intermediate 16, which can undergo corner to
corner nucleophilic rearrangement and cyclopropane ring fission to
generate chain extension. The resulting intermediate 17 can
be deprotonated to generate 18 (path a), or intermediate 17 can be trapped by an active site nucleophile
19, probably by a nonconcerted ionization of 17 (path b), thereby rendering the protein inactive. Stereospecifc
formation of diol 20 with a 24
-hydroxyl group and the
transoid orientation of the 23,24-double bond in
18 during enzyme-catalyzed transformation of 10 provides particularly strong support for the proposition that
orientation effects related to the conformation of the side chain in
binding or transformation are critical to the effectiveness of
substrate analogs as SMT inhibitors (5, 14, 17). It appears most likely
that elongation of the side chain by methylation of C-26 arrested the
ongoing intramolecular rearrangements at the terminating carbocation
and the final deprotonation of C-23 yielded
26-homo-cholesta-8(9),23(24)E,26(26')-trienol 18.
The abortive C-methylation product, diol 20, thus generated
by catalysis of 26,27-DHZ and released from the enzyme by
saponification is diagnostic of the structure and stereochemistry of
the normal enzyme-bound intermediates. A water bridge between the
Glu-68 and the cationic intermediate can also form. In which case,
formation of diol 20 may result from the addition of water
to the cationic intermediate 18. The novel
methylenecyclopropane rearrangement catalyzed by SMT reported for the
first time is unrelated to cyclopropyl sterol synthesis in marine
organisms (31). The mechanism for ring opening of the
methylenecyclopropane of 26,27-DHZ is distinctly different from the
mechanism involved with methylenecyclopropane inactivators studied in
fatty acid metabolism (32).
The detection of the 24
-OH group in diol 20 suggests that
the alkylated enzyme species was formed from the Si face of
the original substrate double bond, on the side of the 24,25-double bond where the carboxylate anion should reside for mechanistic reasons.
However, because Glu-68 is likely involved with 23-deprotonation it
must be spatially distal to the nucleophile involved with C-28 deprotonation. The cyclopropane ring of 26,27-DHZ by virtue of its ring
strain and electron-donating substituent provides structural features
absent from zymosterol that upon catalysis of the acceptor molecule
will allow for Glu-68 to be brought into range of this rotationally
flexible side chain structure.
The exact nature of Glu-68 involvement in zymosterol catalysis is not clear. The generation of 26-homocholesta-8(9),23(24)E,26(26')-trienol 20 from catalysis of 26,27-DHZ by native SMT suggests that Glu-68 acts as a cryptic base in C-23 deprotonation. The failure of AdoMet to bind to the E68L mutant suggests that the acidic amino acid may interact with AdoMet in the active center of the native enzyme as a counterion. Of interest is that the Kd of AdoMet for the SMT was 2 µM similar to the Kd of 11 µM for the AdoMet:glutamyltransferase from Salmonella typhimurium (33).
It seems unlikely that Glu-68 serves as the same active site base
responsible for deprotonation in formation of fecosterol from
zymosterol because no
23-sterols are formed by the yeast
SMT. Given that Glu-68 is a nonconserved residue in fungal SMT
sequences and 26,27-dehydrocycloartenol 10B fails as a
mechanism-based inactivator of the alga P. wickerhamii SMT
indicate the existence of subtle differences between the two groups of
SMTs, perhaps because of sequence variations at or near Glu-68. Because
the methylenecyclopropane structure is a unique inhibitor for S. cerevisiae SMT, it holds the potential to serve as a lead for the
rational design of species-specific agents aimed at modulating SMT
activity, with a view to control and/or regulate ergosterol homeostasis
in the cell.
The high degree of sequence conservation for the signature motif of
Region I in fungi supports a catalytic function for this domain. Region
I is also found in plants with a similar consensus sequence (14).
Site-directed mutagenesis experiments of the acidic residues of the
tryptic digest fragment of the yeast SMT provided additional support
that Region I has a functional role in catalysis and that these
specific amino acids are not deprotonating agents involved with the
conversion of zymosterol to fecosterol. Of the six acidic amino acids
in the tryptic digest fragment, only the leucine mutants of Asp-79 and
Glu-82 elicited substrate channeling. The Asp-79 and Glu-82 mutants
furnished, in addition to fecosterol, a novel C-methylsterol product
with the
25(27)-olefin structure. The deprotonation
leading to the formation of
25(27)-olefin involves
protons chemically and geometrically distinct from that lost in the
generation of
24(28)-olefin indicating a critical
feature of enzymatic control that can lead to multiple olefin
production by a fungal SMT. The isosteric interchange of aspartate or
glutamtate with leucine make the active site region less compact. A
somewhat loosely packed active center may be more flexible thereby
allowing the sterol side chain to develop interactions with polar amino
acids that otherwise would not be contacted during catalysis.
In summary, we observed that the yeast SMT active center, normally
generating a single olefin, has the requisite amino acids to give rise
to multiple olefins that occur naturally in plants. Introduction of the
D79L and E82L mutations into the SMT active site results in the
formation of a mixture of
24(28)- and
25(27)-olefins as the final products, suggesting that
hydrophobic residues in the binding pocket can affect partitioning
through a common high energy intermediate 2 in the SMT. The
acidic amino acids Asp-79 and Glu-82 must lie on the
-face of the
sterol side chain at the time of binding otherwise they would abstract
the proton from H-24 during the 1,2-hydride shift involved with the coupled methylation-deprotonation reaction catalyzed by SMT. The Glu-68
that interacts with the sterol side chain
-face appears to be
essential for catalysis but it is not a likely acidic amino acid unit
for C-28 deprotonation in zymosterol conversion to fecosterol. Finally,
it should be noted that differences in the amino acid composition of
Region I that exist in plants compared with fungi may contribute to the
different sterol specificities and product mixtures catalyzed by SMT isoforms.
| |
FOOTNOTES |
|---|
* This work was supported by Welch Foundation Grant D-1276, National Institutes of Health Grant GM63477, and National Science Foundation Grant MCB 0115401 (to W. D. N.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 806-742-1673;
Fax: 806-742-0135; E-mail: wdavid.nes@ttu.edu.
Published, JBC Papers in Press, August 23, 2002, DOI 10.1074/jbc.M204223200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
SMT, sterol
methyltransferases;
26, 27-DHZ,
[3-3H]26,27-dehydrozymosterol;
AdoMet, S-adenosylmethionine;
HPLC, high performance liquid
chromatography;
MTPA, 2-methoxy-2-phenyl-2-(trifluoromethyl)acetic
acid;
25(27)-olefin, 24-methylzymosta-25(27)-dienol;
24(28)-olefin, fecosterol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Nes, W. D. (2000) Biochim. Biophys. Acta 1529, 63-88[Medline] [Order article via Infotrieve] |
| 2. | Georgopapadakou, N. H. (1998) Curr. Opin. Microbiol. 1, 547-557[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Nes, W. R.,
Sekula, B. C.,
Nes, W. D.,
and Adler, J. H.
(1978)
J. Biol. Chem.
253,
6218-6225 |
| 4. | Bloch, K. E. (1983) CRC Crit. Rev. Biochem. 14, 47-92[Medline] [Order article via Infotrieve] |
| 5. |
Janssen, G. G.,
and Nes, W. D.
(1992)
J. Biol. Chem.
267,
25856-25863 |
| 6. | Beuchet, P., Dherbomez, L., Charles, E. G., and Letourneux, Y. (1999) Biooorg. Med. Chem. Lett. 9, 1599-1600[CrossRef] |
| 7. | Contreras, L. M., Vivas, J., and Urbina, J. A. (1997) Biochem. Pharmacol. 53, 697-704[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Chung, S-K., Ryoo, C. H., Yang, H. W., Shim, J-Y., Kang, M. G., Lee, K. W., and Kang, H. I. (1998) Tetrahedron 54, 15899-15914[CrossRef] |
| 9. | Urbina, J. A., Visba, G., Conreras, L. M., Mclaughlin, G., and Docampo, R. (1997) Antimicrob. Agents Chemother. 41, 1428-1432[Abstract] |
| 10. | Hardwick, K. G., and Pelham, H. R. B. (1994) Yeast 10, 265-269[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Nes, W. D., McCourt, B. S., Zhou, W-X., Ma, J. A., Marshall, J. A., Peek, L-A., and Brennan, M. (1998) Arch. Biochem. Biophys. 353, 297-311[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Nes, W. D., Guo, D., and Zhou, W. (1997) Arch. Biochem. Biophys. 342, 68-81[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Guo, D., Jia, Z., and Nes, W. D. (1996) J. Am. Chem. Soc. 118, 8507-8508[CrossRef] |
| 14. | Nes, W. D., McCourt, B. S., Marshall, J. A., Ma, J., Dennis, A. L., Lopez, M., Li, H., and Le, H. (1999) J. Org. Chem. 64, 1535-1542[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Mihailovic, M. (1984) Biosynthesis of Phytosterols in Trebouxia sp.: Steric Course of the C-Alkylation Step. Dissertation , Swiss Federal Institute of Technology, Zurich, Switzerland |
| 16. | Kalinowska, M., Nes, W. R., Crumley, F. G., and Nes, W. D. (1990) Phytochemistry 29, 3427-3434[CrossRef] |
| 17. |
Nes, W. D.,
Janssen, G. G.,
and Bergenstrahle, A.
(1991)
J. Biol. Chem.
266,
15202-15212 |
| 18. | Goad, L. J., Lenton, J. R., Knapp, F. F., and Goodwin, T. W. (1974) Lipids 9, 582-595[Medline] [Order article via Infotrieve] |
| 19. | Giner, J., and Djerasssi, C. (1991) J. Am. Chem. Soc. 113, 1386-1393 |
| 20. | Marshall, J. A., and Nes, W. D. (1999) Bioorg. Med. Chem. Lett. 9, 1533-1536[Medline] [Order article via Infotrieve] |
| 21. | Croteau, R., Alonso, W. R., Koepp, A. E., Shim, J. A., and Cane, D. E. (1993) Arch. Biochem. Biophys. 307, 397-404[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Venkatramesh, M., Guo, D., Jia, Z., and Nes, W. D. (1996) Biochim. Biophys. Acta 1299, 313-324[Medline] [Order article via Infotrieve] |
| 23. | Bradford, M. M. (1976) Anal. Chem. 72, 248-254 |
| 24. | Copeland, R. A. (2000) Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis , 2nd Ed. , John Wiley & Sons, Inc., New York |
| 25. | Nes, W. D., He, L., and Mangla, A. T. (1998) Bioorg. Med. Chem. Lett. 8, 3449-3452[Medline] [Order article via Infotrieve] |
| 26. | Harwood, L. M., and Claridge, D. W. (1997) Introduction to Organic Spectroscopy , pp. 48-50, Oxford Science Publishers, Oxford |
| 27. | Jia, Z., Zhou, W., Guo, D., and Nes, W. D. (1996) Synth. Commun. 26, 1533-1536 |
| 28. | Wakefield, B. J. (1995) Organomagenisum Methods in Organic Synthesis , Academic Press, San Diego, CA |
| 29. | Ohtani, I., Kusumi, T., Kashman, Y., and Kakisawa, H. (1991) J. Am. Chem. Soc. 113, 4092-4096[CrossRef] |
| 30. |
Rahier, A.,
Genot, J-C.,
Schuber, F.,
Benveniste, P.,
and Narula, A. S.
(1984)
J. Biol. Chem.
259,
15215-15223 |
| 31. | Giner, J-L., Buzek, P., and Schleyer, P. R. (1995) J. Am. Chem. Soc. 117, 12871-12877 |
| 32. | Ding, L., Agnihotri, G., Dakoji, S., Oh, E., Lantz, M., and Liu, H-W. (1999) J. Am. Chem. Soc. 121, 9034-9042[CrossRef] |
| 33. |
Simms, S. A.,
and Subbaramiah, K.
(1991)
J. Biol. Chem.
266,
12741-12746 |
This article has been cited by other articles:
![]() |
W. Zhou, G. I. Lepesheva, M. R. Waterman, and W. D. Nes Mechanistic Analysis of a Multiple Product Sterol Methyltransferase Implicated in Ergosterol Biosynthesis in Trypanosoma brucei J. Biol. Chem., March 10, 2006; 281(10): 6290 - 6296. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Nes, Z. Song, A. L. Dennis, W. Zhou, J. Nam, and M. B. Miller Biosynthesis of Phytosterols: KINETIC MECHANISM FOR THE ENZYMATIC C-METHYLATION OF STEROLS J. Biol. Chem., September 5, 2003; 278(36): 34505 - 34516. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||